American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Abdel-Wahab
    Abdel-Wahab
  10. Kernan
    Kernan

Groups

  1. Department of Medicine (3950)
  2. Hematologic Malignancies, Division of (3750)
  3. Center for Hematologic Malignancies (3637)
  4. GSK Faculty (1584)
  5. Adult Leukemia (1328)
  6. Sloan Kettering Institute Faculty (1071)
  7. Bone Marrow Transplant (967)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (952)
  9. Lymphoma (928)
  10. Tow Center for Developmental Oncology (TCDO) (878)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1242)
  3. Research Letter (44)
  4. Review (44)
  5. Editorial (34)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (3950)
  2. Hematologic Malignancies, Division of (3750)
  3. Center for Hematologic Malignancies (3637)
  4. GSK Faculty (1584)
  5. Adult Leukemia (1328)
  6. Sloan Kettering Institute Faculty (1071)

More Groups

People
  1. Sergio Giralt (346)
  2. Andrew Zelenetz (340)
  3. Ross Levine (315)
  4. Miguel-Angel Perales (303)
  5. Martin Tallman (300)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (46)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5165)
  2. Blood Advances (322)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5537)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Probing the AML surfaceome for chimeric antigen receptor (CAR) targets
    Meeting Abstract

    Perna, F.; Berman, S.; Mansilla-Soto, J.; Hamieh, M.; Juthani, R.; Soni, R.; Eyquem, J.; Hendrickson, R.; Brennan, C.; Sadelain, M.
    Blood (2016)

    Fulltext@MSK | Save
  • Chromatin state dynamics underlying CD8 T cell differentiation and dysfunction in cancer
    Meeting Abstract

    Philip, M.; Fairchild, L.; Sun, L.; Viale, A.; Merghoub, T.; Wolchok, J. D.; Leslie, C. S.; Schietinger, A.
    Blood (2016)

    Fulltext@MSK | Save
  • Third party CMV-specific cytotoxic T cells for treatment of antiviral resistant CMV infection after hematopoietic stem cell transplant
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Hasan, A. N.; Dahi, P. B.; Giralt, S.; Koehne, G.; Kernan, N. A.; Papadopoulos, E. B.; Lehrman, R.; Rodriguez-Sanchez, I.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Synergistic therapeutic efficacy of combined JAK1/2, pan-PIM, and CDK4/6 inhibition in myeloproliferative neoplasms
    Meeting Abstract

    Rampal, R. K.; Maria, P. O.; Amritha Varshini, H. S.; Levine, R. L.; Cao, A.
    Blood (2016)

    Fulltext@MSK | Save
  • Changes of the mutational landscape in relapsed acute myeloid leukemia
    Meeting Abstract

    Rapaport, F.; de Massy, M. R.; al Hinai, A.; Sanders, M. A.; Hricik, T.; Sheridan, C.; Lee, T. C.; Neelamraju, Y.; Patel, J.; Chung, S. S.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Durable overall survival benefit in patients >= 60 years with relapsed or refractory AML treated with vosaroxin/cytarabine vs placebo/cytarabine: Updated results from the valor trial
    Meeting Abstract

    Ravandi, F.; Ritchie, E. K.; Sayar, H.; Lancet, J. E.; Craig, M.; Vey, N.; Strickland, S. A.; Schiller, G. J.; Jabbour, E. J.; Erba, H. P.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Predictive value of mutation analysis in the diagnostic approach to patients with unexplained cytopenia
    Meeting Abstract

    Malcovati, L.; Gallì€, A.; Travaglino, E.; Ambaglio, I.; Rizzo, E.; Molteni, E.; Elena, C.; Catricalà€, S.; Bono, E.; Bianchessi, A.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Loss of adrenergic nerves in the bone marrow microenvironment drives an aging HSC niche phenotype
    Meeting Abstract

    Maryanovich, M.; Zahalka, A. H.; Pierce, H.; Pinho, S.; Nakahara, F.; Asada, N.; Leftin, A.; Vijg, J.; Frenette, P. S.
    Blood (2016)

    Fulltext@MSK | Save
  • Interim PET evaluation by Deauville criteria is an effective risk stratification tool in PTCL
    Meeting Abstract

    Mehta-Shah, N.; Ito, K.; Bantilan, K. S.; Moskowitz, A. J.; Sauter, C. S.; Horwitz, S. M.; Schoder, H.
    Blood (2016)

    Fulltext@MSK | Save
  • Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma
    Meeting Abstract

    Mondello, P.; Derenzini, E.; Asgari, Z.; Philip, J.; Brea, E. J.; Seshan, V. E.; Hendrickson, R.; de Stanchina, E.; Scheinberg, D. A.; Younes, A.
    Blood (2016)

    Fulltext@MSK | Save